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        Epiretinal membrane (ERM) is a non-vascular fibrocellular proliferation that 23 
develops on the surface of the internal limiting membrane, resulting in retinal 24 
wrinkling and distortion. The prevalence of ERM formation is 5.3% to 18.5% of 25 
the population. 1-4 The first report of successful removal of ERM was published 26 
by Machemer in 1978.5 Since then, favorable visual outcome has been 27 
achieved in the majority of cases postoperatively.6-10 Visual acuity improves in 28 
many patients after successful removal of ERM, whereas it has been reported 29 
that metamorphopsia can still be present even if ERM was successfully 30 
removed with improvement of visual acuity.11 Metamorphopsia occurring in eyes 31 
with ERM is one of the most common conditions responsible for deterioration in 32 
vision-related quality of life (VR-QOL); however, relatively little attention has 33 
been paid to the relationship between metamorphopsia and VR-QOL in patients 34 
with ERM. 35 
       In ophthalmology, traditional objective clinical outcome measures such as 36 
visual acuity are increasingly being complemented with assessment of patients’ 37 
perception of their visual function and quality of life. The National Eye Institute 38 
25-Item Visual Function Questionnaire (VFQ-25) is a VR-QOL instrument 39 
designed to assess patients’ perception of their visual function and QOL.12 The 40 
VFQ-25 has been used to track the outcome of many ocular diseases such as 41 
cataract, glaucoma, age-related macular degeneration, diabetic retinopathy, 42 
macular hole, rhegmatogenous retinal detachment, and keratoconus.13-22 43 
       A recent study using VFQ-25 demonstrated that vitrectomy for ERM had a 44 
beneficial effect on patients’ subjective perception of visual function, and the 45 
VFQ-25 responses correlated with visual acuity, but not with contrast sensitivity 46 
and metamorphopsia in patients with ERM. 23 This study used the Amsler charts, 47 
which have been widely used to detect and evaluate metamorphopsia in 48 
patients with macular diseases.24-25 With the Amsler charges, however, it is 49 
difficult to quantify the severity of metamorphopsia because the patients have to 50 
self describe the degree of image distortion. An M-CHARTS (Inami Co., Tokyo, 51 
Japan) is an instrument which can easily and quantitatively evaluate the degree 52 
of metamorphopsia associated with macular diseases, with the patients only to 53 
answer whether the line is distorted or not.26-27 The purpose of this study was to 54 
evaluate VR-QOL in patients with ERM, and to investigate the relationship 55 
between VR-QOL and visual function including metamorphopsia. 56 
 57 
Methods 58 
Patients 59 
We included 28 eyes of 28 consecutive patients with ERM who were 60 
undergoing pars plana vitrectomy at Tsukuba University Hospital between July 61 
28, 2005, and February 20, 2007. There were 13 males and 15 females, and their 62 
age averaged 66.7 ± 8.5 years (mean ± SD). Twenty-six age-matched subjects 63 
served as normal controls (12 males and 14 females, age 64.1 ± 10.4 years). 64 
This study was conducted in accordance with the tenets of the Declaration of 65 
Helsinki, and the study protocol was approved by the institutional review 66 
committees. Prior to inclusion in the study, the nature of the study was explained 67 
to all patients, and their written informed consent was obtained. ERM was defined 68 
as a translucent or semi-translucent membrane with macular thickening involving 69 
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the center of the macula, with or without distortion and wrinkling of the inner 70 
retinal surface on biomicroscopy and optical coherence tomography (OCT). 71 
Exclusion criteria included patients with a previous history of vitreoretinal surgery 72 
and ophthalmic disorders, except for mild refractive errors and mild cataract. 73 
Eyes with secondary ERM due to retinal vascular disease, uveitis, trauma, and 74 
retinal breaks were also excluded from the study.  75 
Data were collected for logMAR best-corrected visual acuity (BCVA), letter 76 
contrast sensitivity, and metamorphopsia preoperatively and at 3 months 77 
postoperatively. Letter contrast sensitivity was measured using the CSV-1000LV 78 
chart (Vector Vision, Columbus, Ohio).  79 
The severity of metamorphopsia was evaluated by the M-Charts. M-Charts 80 
consist of 19 dotted lines with dot intervals ranging from 0.2 degrees to 2.0 81 
degrees of visual angle. If the straight line is substituted with a dotted line and the 82 
dot interval is changed from fine to coarse, the distortion of the line decreases 83 
with the increasing dot interval, until the dotted line appears straight.26,27 At first, 84 
vertical straight lines (0 degrees) were shown to the patient. If the patient 85 
recognized the straight line as straight, the metamorphopsia score was 0. If the 86 
patient recognized the straight line as irregular or curved, then subsequent pages 87 
of M-Charts, in which the dot intervals of the dotted line change from fine to 88 
coarse, were shown one after another. When the patient recognized a dotted line 89 
as being straight, the visual angle that separated the dots was considered to 90 
represent his/her metamorphopsia score for vertical line. Also, the M-Charts were 91 
rotated 90 degrees and the same test is performed using horizontal lines. The 92 
examinations were repeated three times for each subject to evaluated the 93 
reproducibility of the test, and their mean was used for data analyses. The 94 
examination was performed at 30 cm and the refraction of the eye was exactly 95 
corrected for this distance. 96 
 Central macular thickness was measured using OCT (Stratus OCT 3000, 97 
Carl Zeiss Ophthalmic Systems-Humphrey Division, Dublin, CA, USA) 98 
preoperatively and at 3 months postoperatively. OCT was performed with the fast 99 
macular thickness map mode, and central macular thickness was obtained from 100 
the retinal map analysis function.  101 
 102 
Surgical procedures 103 
All surgeries were performed by a single surgeon (F.O.) under sub-Tenon 104 
local anesthesia. The lens was removed by phacoemulsification and intraocular 105 
lens implantation when required, following which vitrectomy was performed. The 106 
surgical technique used was standard 20-gauge three-port pars plana vitrectomy. 107 
With conventional contact lenses, posterior hyaloid separation and removal of the 108 
posterior vitreous membrane were performed. The ERM was engaged and 109 
removed from the macula with a pick and intraocular forceps. Peripheral retinal 110 
examination with scleral depression was performed to search for a retinal tear or 111 
dialysis. Air-fluid exchange was performed if iatrogenic retinal tear and/or 112 
rhegmatogenous retinal detachment were identified intraoperatively. 113 
 114 
VFQ-25 115 
The patients answered VFQ-25 preoperatively and 3 months 116 
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postoperatively. Preoperative VFQ-25 was administered 1-2 days before surgery. 117 
The research staff explained the questionnaire to the patients, verbally 118 
administered instructions, and provided assistance when required. The 119 
completed questionnaires were reviewed for missing data by the research staff. 120 
Prior to surgery, all the missing items were incorporated by the subjects 121 
themselves. 122 
The VFQ-25 comprises 25 items wherein patients are expected to assess 123 
the level of difficulty of particular visual symptoms or day-to-day activities. Each 124 
item is assigned to one of the 12 subscales, namely, general health, general 125 
vision, ocular pain, near activities, distance activities, social functioning, mental 126 
health, role difficulties, dependency, driving, color vision, and peripheral vision. 127 
The subscales are scored on a 0- to 100-point scale, where 100 indicates the 128 
highest possible function or the minimal subjective impairment. The VFQ-25 129 
composite score is calculated as the unweighted average response to all items, 130 
excluding the questions on general health.12 The VFQ-25 used in this study was a 131 
Japanese version, with modifications to suit the Japanese culture and lifestyle. 132 
The modified NEI VFQ-25 questionnaire has been assessed for reliability and 133 
validity, and it has been proven to accurately measure VR-QOL in Japanese 134 
individuals.13 135 
 136 
Statistical analysis 137 
       The mean scores and standard deviations were calculated for each VFQ-25 138 
subscale as well as composite score, in patients with ERM and normal controls. 139 
The Mann-Whitney U test was performed to compare each subscale score and 140 
composite score between ERM patients and normal controls. The Wilcoxon 141 
signed-ranks test was used to compare preoperative and postoperative results. 142 
The relationship between the questionnaire scores and visual acuity, contrast 143 
sensitivity, metamorphopsia, central macular thickness, and age were examined 144 
by the Spearman rank correlation test. All tests of association were considered 145 
statistically significant if P < 0.05. The analyses were carried out using StatView 146 
(version 5.0, SAS Inc., Cary, NC, USA). 147 
 148 
Results 149 
Among the 28 patients with ERM, 8 were pseudophakic and 20 were phakic. 150 
Eighteen of 20 patients who had slight or moderate lens opacity underwent 151 
combined cataract surgery and vitrectomy to avoid cataract formation following 152 
vitrectomy. No significant intraoperative and postoperative complications were 153 
observed, such as retinal detachment, choroidal detachment, subretinal 154 
hemorrhage, cataract formation, and infection. Air-fluid exchange was performed 155 
in 7 patients because of intraoperative identification of retinal tears. In 2 patients, 156 
intraocular pressure elevated above than 25 mmHg, and antihypertensive agent 157 
was administered. These patients responded to treatment, and antihypertensive 158 
agent was discontinued within 3 days. 159 
Vitrectomy significantly improved logMAR BCVA from 0.495 ± 0.293 160 
preoperatively to 0.245 ± 0.294 postoperatively (P < 0.0001). Sixteen patients 161 
(57.1%) gained 2 or more early treatment diabetic retinopathy study (ETDRS) 162 
lines. No change in logMAR BCVA was observed in 11 eyes (39.3%), and vision 163 
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decreased by 1 or more lines in 1 patient (3.6%). The postoperative reduction in 164 
visual acuity was attributed to retinal atrophy of the macula. Twenty-seven 165 
(96.4%) patients underwent ERM surgery in their worse-seeing eye. LogMAR 166 
BCVA in the fellow eye was 0.062 ± 0.191. The letter contrast sensitivity 167 
significantly increased from 14.6 ± 5.3 preoperatively to 18.6 ± 5.5 168 
postoperatively (P < 0.0001). The severity of metamorphopsia also significantly 169 
improved from 0.79 ± 0.47 preoperatively to 0.33 ± 0.44 postoperatively (P = 170 
0.0005). Central macular thickness also significantly improved from 440 ± 106 171 
μm to 315 ± 89 μm (P < 0.0001).  172 
The results of VFQ-25 questionnaire pre- and postoperatively are 173 
summarized in Table 1. The preoperative VFQ-25 composite score was 174 
significantly lower in the ERM patients than in the normal controls (P < 0.0001). 175 
The preoperative subscale scores were significantly lower in the ERM patients 176 
than in the normal controls in all subscales, except for general health and ocular 177 
pain. Membrane peeling surgery significantly improved VFQ-25 composite score 178 
(P < 0.0001) and the scores in 10 out of 12 subscales, except for general health 179 
and peripheral vision. However, postoperative VFQ-25 composite score still 180 
remained significantly lower in the ERM patients than in the normal controls (P < 181 
0.0001). 182 
The preoperative VFQ-25 composite score exhibited significant correlation 183 
with the severity of preoperative metamorphopsia (r = –0.411, P < 0.05, Fig 1). No 184 
correlation was observed between preoperative VFQ-25 composite score and 185 
preoperative logMAR BCVA (r = 0.018, P = 0.928), letter contrast sensitivity (r = 186 
0.092, P = 0.659), central macular thickness (r = 0.162, P = 0.415), and age (r = 187 
–0.010, P = 0.960).   188 
The postoperative VFQ-25 composite score exhibited significant correlation 189 
with the severity of postoperative metamorphopsia (r = –0.393, P < 0.05, Fig 2) 190 
and postoperative logMAR BCVA (r = –0.373, P < 0.05), but not with letter 191 
contrast sensitivity (r = 0.170, P = 0.411).  The correlation between the 192 
postoperative VFQ-25 composite score and central macular thickness was 193 
borderline significance (r = –0.372, P = 0.051). 194 
Changes in VFQ-25 composite score significantly correlated with changes 195 
in the severity of metamorphopsia (r = –0.411, P < 0.05, Fig 3). There was no 196 
significant correlation between changes in VFQ-25 composite score and changes 197 
in logMAR BCVA (r = -0.076, P = 0.705), letter contrast sensitivity (r = 0.267, P = 198 
0.189), and central macular thickness (r = 0.05, P = 0.804).  199 
LogMAR BCVA in the fellow eye did not show any significant relationship 200 
with preoperative VFQ-25 composite score (r = 0.115, p = 0.563), postoperative 201 
VFQ-25 composite score (r = 0.156, p = 0.432), and changes in VFQ-25 202 
composite score (r = -0.178, p = 0.369). 203 
 204 
Discussion 205 
In the present study, VFQ-25 composite score and all subscale scores, 206 
except for general health and ocular pain, were significantly deteriorated in 207 
patients with ERM compared to the normal controls. Vitrectomy to remove ERM 208 
significantly improved not only visual acuity, contrast sensitivity, and central 209 
macular thickness, but also VFQ-25 scores. Previous studies have reported that 210 
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the mean VFQ-25 composite scores after vitreoretinal surgery in patients with 211 
macular hole, rhegmatogenous retinal detachment, proliferative diabetic 212 
retinopathy, and age-related macular degeneration were 82.4,18 80.3,21 68.5,20 213 
and 54.4, 17 respectively. The mean VFQ-25 composite score after ERM surgery 214 
in this study (77.9) was similar to those after macular hole and rhegmatogenous 215 
retinal detachment surgery and higher than those after vitrectomy for proliferative 216 
diabetic retinopathy and age-related macular degeneration.  217 
ERM surgery significantly improved the mean VFQ-25 composite score 218 
from 66.2 preoperatively to 77.9 postoperatively. This improvement of VR-QOL in 219 
patients with ERM was higher than these in macular hole and age-related 220 
macular degeneration. 17-18 Gupta OP et al. demonstrated that ERM surgery was 221 
a very cost-effective procedure using quality-adjusted-life-years (QALYs) 222 
methods. 28 The cost-effectiveness ratio for ERM surgery was higher than 223 
macular hole surgery. Thus, ERM surgery improved VR-QOL and was 224 
cost-effective intervention compared other vitreoretinal surgeries. 225 
As shown in the results, even after successful membrane peeling surgery in 226 
patients with ERM, VR-QOL remained at a lower level than the normal controls. 227 
This finding is consistent with the results of previous case-control studies on 228 
VR-QOL for retinal disorders such as rhegmatogenous retinal detachment and 229 
proliferative diabetic retinopathy.20,21 230 
In our study, VR-QOL was significantly associated with the severity of 231 
metamorphopsia before and after surgery. In addition, changes in VR-QOL were 232 
associated with changes in metamorphopsia. This observation is not consistent 233 
with the results of previous studies in patients with ERM and macular hole.23,24 234 
Ghazi-Nouri et al. showed that VFQ-25 responses correlated with visual acuity 235 
but not with contrast sensitivity and metamorphopsia in patients with ERM. 23 236 
Tranos et al. investigated VR-QOL in patients with macular hole and observed 237 
that postoperative VFQ-25 responses significantly correlated with postoperative 238 
metamorphopsia, whereas preoperative and change in VFQ-25 composite score 239 
by surgery were not associated with the degree of metamorphopsia.24 Such 240 
discrepancy between our and previous studies may be attributable to the different 241 
methods of evaluating metamorphopsia. In previous studies, the severity of 242 
metamorphopsia was graded using the Amsler charts, which have been widely 243 
used to detect metamorphopsia in macular diseases.24,25 As the methods of 244 
evaluating metamorphopsia are numbered distorted squares on the Amsler chart, 245 
the result indicates mainly extent of central metamorphopsia. On the other hand, 246 
the M-Charts have been used to quantify severity of metamorphopsia in patients 247 
with ERM and macular hole. 26,27,29 The M-Charts can evaluate frequency 248 
components of distortion in metamorphopsia. The fine high frequency component 249 
of metamorphopsia which is usually observed in mild ERM is detect by fine dotted 250 
lines, however, it is not detected by coarse dotted lines. In severe ERM, the large 251 
amplitude and low frequency components of metamorphopsia increase, so it is 252 
easy to detect by all kinds of lines, including coarse dotted lines. Thus, VR-QOL 253 
seems to be associated with the frequency components of distortion in 254 
metamorphopsia, but not with extent of central metamorphopsia.  255 
The preoperative VFQ-25 composite score significantly correlated with the 256 
severity of preoperative metamorphopsia, but not with preoperative visual acuity. 257 
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In addition, changes in VFQ-25 composite score correlated with changes in 258 
metamorphopsia, but not with changes in visual acuity. Many studies have shown 259 
that visual acuity correlates with VR-QOL in patients with vitreoretinal disorders 260 
such as ERM, macular hole, proliferative diabetic retinopathy, age-related 261 
macular degeneration, and central retinal vein occlusion .18,20,23,30-32 The 262 
preoperative visual acuities in this study were relatively good with a mean 263 
preoperative logMAR BCVA of 0.495 and a mean postoperative logMAR BCVA 264 
of 0.295. These good preoperative visual acuities may also explain why VFQ-25 265 
did not correlate with visual acuity since patients had not lost that much vision 266 
before they had surgery. Wong JG et al. interviewed 91 patients with ERM to 267 
assess the influence of surgery on functional vision.33 They reported that 268 
frequency of patients with ERM complained of moderate to severe distortion 269 
decreased from 80% to 30% by surgery. On the other hand, the frequency of 270 
patients complained of visual disturbance decreased from 55% to 30% by 271 
surgery. Bouwens MD et al. quantitatively evaluated the severity of 272 
metamorphopsia in patients undergoing ERM using Sine Amsler Chart and 273 
observed that metamorphopsia improved in 82% patients, while visual acuity 274 
improved only in 48% by surgery.11 Judging from these previous and our findings, 275 
it seems that ERM peeling surgery is highly effective in improving 276 
metamorphopsia, but significant improvement of visual acuity may not be 277 
expected in many cases. In practice, surgical indication and outcome measures 278 
are judged mainly based on visual acuity parameters.6-10 Postoperatively, 279 
however, many patients complain of significant symptoms other than blurred 280 
vision, especially distortion, which is not adequately reflected by visual acuity 281 
assessment. In light of VR-QOL, we must pay more attention to the degree of and 282 
changes in metamorphopsia in patients with ERM. 283 
Our study has several limitations. First, there may be some placebo effect 284 
for taking the VFQ-25 before and after surgery. The patients obviously know they 285 
had surgery and may have answered the VFQ-25 questions more positively 286 
following surgery due to an expectation that they would benefit from the surgery. 287 
This cannot be avoided by the study design, but could account for some of the 288 
improvements in the VFQ-25. Second, the sample size in our study was rather 289 
small, and that may have influenced the relationship between visual function and 290 
VFQ-25 scores. Third, postoperative follow-up was short. We evaluated the 291 
patients at 3 months postoperatively. A long-term follow-up study in vitrectomy for 292 
ERM reported that visual improvement was archived in 43% of eyes at 6 to 12 293 
months, in 54% at 1 to 2 years, and 60% at 2 to 3 years.10 Future studies with a 294 
larger sample size and longer follow-up period will further facilitate our 295 
understanding of the relationship between VR-QOL and visual function in patients 296 
undergoing surgery for ERM.  297 
 298 
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Figure legends 409 
Figure 1. Preoperative National Eye Institute 25-Item Visual Function 410 
Questionnaire (VFQ-25) composite score vs. severity of preoperative 411 
metamorphopsia in patients with epiretinal membrane. 412 
 413 
Figure 2. Postoperative National Eye Institute 25-Item Visual Function 414 
Questionnaire (VFQ-25) composite score vs. severity of postoperative 415 
metamorphopsia in patients with epiretinal membrane. 416 
 417 
Figure 3. Changes in National Eye Institute 25-Item Visual Function 418 
Questionnaire (VFQ-25) composite score vs. changes in severity of 419 
metamorphopsia after epiretinal membrane peeling surgery. 420 
 421 
